AustralieFrV1, Main, Exploration, bibRecord, 001230

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.

Identifieur interne : 001230 ( Main/Exploration ); précédent : 001229; suivant : 001231

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.

Auteurs : Boni E. Elewski [États-Unis] ; Martin M. Okun [États-Unis] ; Kim Papp [Canada] ; Christopher S. Baker [Australie] ; Jeffrey J. Crowley [États-Unis] ; Gérard Guillet [France] ; Murali Sundaram [États-Unis] ; Yves Poulin [Canada] ; Yihua Gu [États-Unis] ; Ziqian Geng [États-Unis] ; David A. Williams [États-Unis] ; Phoebe A. Rich [États-Unis]

Source :

Journal of the American Academy of Dermatology [ 1097-6787 ] ; 2017.

RBID : pubmed:28993005

Abstract

Previous clinical trials have not evaluated improvement in nail psoriasis as a primary end point.

DOI: 10.1016/j.jaad.2017.08.029
PubMed: 28993005

Affiliations:

Australie, Canada, France, États-Unis
Alabama, Californie, Illinois, Nouvelle-Aquitaine, Oregon, Pennsylvanie, Poitou-Charentes, Wisconsin
Poitiers

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.</title>
<author><name sortKey="Elewski, Boni E" sort="Elewski, Boni E" uniqKey="Elewski B" first="Boni E" last="Elewski">Boni E. Elewski</name>
<affiliation wicri:level="2"><nlm:affiliation>University of Alabama at Birmingham School of Medicine, Birmingham, Alabama. Electronic address: beelewski@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Alabama</region>
</placeName>
<wicri:cityArea>University of Alabama at Birmingham School of Medicine, Birmingham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Okun, Martin M" sort="Okun, Martin M" uniqKey="Okun M" first="Martin M" last="Okun">Martin M. Okun</name>
<affiliation wicri:level="2"><nlm:affiliation>Fort Healthcare, Fort Atkinson, Wisconsin.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>Fort Healthcare, Fort Atkinson</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Papp, Kim" sort="Papp, Kim" uniqKey="Papp K" first="Kim" last="Papp">Kim Papp</name>
<affiliation wicri:level="1"><nlm:affiliation>K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baker, Christopher S" sort="Baker, Christopher S" uniqKey="Baker C" first="Christopher S" last="Baker">Christopher S. Baker</name>
<affiliation wicri:level="1"><nlm:affiliation>Skin and Cancer Foundation Inc and Probity Medical Research, Carlton, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Skin and Cancer Foundation Inc and Probity Medical Research, Carlton, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Crowley, Jeffrey J" sort="Crowley, Jeffrey J" uniqKey="Crowley J" first="Jeffrey J" last="Crowley">Jeffrey J. Crowley</name>
<affiliation wicri:level="2"><nlm:affiliation>Bakersfield Dermatology, Bakersfield, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Bakersfield Dermatology, Bakersfield</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guillet, Gerard" sort="Guillet, Gerard" uniqKey="Guillet G" first="Gérard" last="Guillet">Gérard Guillet</name>
<affiliation wicri:level="3"><nlm:affiliation>Hopital La Miletrie, Service de Dermatologie, CHU Poitiers, Poitiers, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hopital La Miletrie, Service de Dermatologie, CHU Poitiers, Poitiers</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sundaram, Murali" sort="Sundaram, Murali" uniqKey="Sundaram M" first="Murali" last="Sundaram">Murali Sundaram</name>
<affiliation wicri:level="2"><nlm:affiliation>Janssen Scientific Affairs, Horsham, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Janssen Scientific Affairs, Horsham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Poulin, Yves" sort="Poulin, Yves" uniqKey="Poulin Y" first="Yves" last="Poulin">Yves Poulin</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre de Recherche Dermatologique du Québec Métropolitain, Québec City, Québec, Canada; Laval University, Québec City, Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre de Recherche Dermatologique du Québec Métropolitain, Québec City, Québec, Canada; Laval University, Québec City, Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gu, Yihua" sort="Gu, Yihua" uniqKey="Gu Y" first="Yihua" last="Gu">Yihua Gu</name>
<affiliation wicri:level="2"><nlm:affiliation>AbbVie Inc, North Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>AbbVie Inc, North Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Geng, Ziqian" sort="Geng, Ziqian" uniqKey="Geng Z" first="Ziqian" last="Geng">Ziqian Geng</name>
<affiliation wicri:level="2"><nlm:affiliation>AbbVie Inc, North Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>AbbVie Inc, North Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Williams, David A" sort="Williams, David A" uniqKey="Williams D" first="David A" last="Williams">David A. Williams</name>
<affiliation wicri:level="2"><nlm:affiliation>AbbVie Inc, North Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>AbbVie Inc, North Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Rich, Phoebe A" sort="Rich, Phoebe A" uniqKey="Rich P" first="Phoebe A" last="Rich">Phoebe A. Rich</name>
<affiliation wicri:level="2"><nlm:affiliation>Oregon Health and Science University Hospital, Portland, Oregon.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Oregon</region>
</placeName>
<wicri:cityArea>Oregon Health and Science University Hospital, Portland</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28993005</idno>
<idno type="pmid">28993005</idno>
<idno type="doi">10.1016/j.jaad.2017.08.029</idno>
<idno type="wicri:Area/PubMed/Corpus">000388</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000388</idno>
<idno type="wicri:Area/PubMed/Curation">000386</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000386</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000386</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000386</idno>
<idno type="wicri:Area/Ncbi/Merge">005001</idno>
<idno type="wicri:Area/Ncbi/Curation">005001</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005001</idno>
<idno type="wicri:Area/Main/Merge">001225</idno>
<idno type="wicri:Area/Main/Curation">001230</idno>
<idno type="wicri:Area/Main/Exploration">001230</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.</title>
<author><name sortKey="Elewski, Boni E" sort="Elewski, Boni E" uniqKey="Elewski B" first="Boni E" last="Elewski">Boni E. Elewski</name>
<affiliation wicri:level="2"><nlm:affiliation>University of Alabama at Birmingham School of Medicine, Birmingham, Alabama. Electronic address: beelewski@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Alabama</region>
</placeName>
<wicri:cityArea>University of Alabama at Birmingham School of Medicine, Birmingham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Okun, Martin M" sort="Okun, Martin M" uniqKey="Okun M" first="Martin M" last="Okun">Martin M. Okun</name>
<affiliation wicri:level="2"><nlm:affiliation>Fort Healthcare, Fort Atkinson, Wisconsin.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>Fort Healthcare, Fort Atkinson</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Papp, Kim" sort="Papp, Kim" uniqKey="Papp K" first="Kim" last="Papp">Kim Papp</name>
<affiliation wicri:level="1"><nlm:affiliation>K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baker, Christopher S" sort="Baker, Christopher S" uniqKey="Baker C" first="Christopher S" last="Baker">Christopher S. Baker</name>
<affiliation wicri:level="1"><nlm:affiliation>Skin and Cancer Foundation Inc and Probity Medical Research, Carlton, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Skin and Cancer Foundation Inc and Probity Medical Research, Carlton, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Crowley, Jeffrey J" sort="Crowley, Jeffrey J" uniqKey="Crowley J" first="Jeffrey J" last="Crowley">Jeffrey J. Crowley</name>
<affiliation wicri:level="2"><nlm:affiliation>Bakersfield Dermatology, Bakersfield, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Bakersfield Dermatology, Bakersfield</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guillet, Gerard" sort="Guillet, Gerard" uniqKey="Guillet G" first="Gérard" last="Guillet">Gérard Guillet</name>
<affiliation wicri:level="3"><nlm:affiliation>Hopital La Miletrie, Service de Dermatologie, CHU Poitiers, Poitiers, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hopital La Miletrie, Service de Dermatologie, CHU Poitiers, Poitiers</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sundaram, Murali" sort="Sundaram, Murali" uniqKey="Sundaram M" first="Murali" last="Sundaram">Murali Sundaram</name>
<affiliation wicri:level="2"><nlm:affiliation>Janssen Scientific Affairs, Horsham, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Janssen Scientific Affairs, Horsham</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Poulin, Yves" sort="Poulin, Yves" uniqKey="Poulin Y" first="Yves" last="Poulin">Yves Poulin</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre de Recherche Dermatologique du Québec Métropolitain, Québec City, Québec, Canada; Laval University, Québec City, Québec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre de Recherche Dermatologique du Québec Métropolitain, Québec City, Québec, Canada; Laval University, Québec City, Québec</wicri:regionArea>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gu, Yihua" sort="Gu, Yihua" uniqKey="Gu Y" first="Yihua" last="Gu">Yihua Gu</name>
<affiliation wicri:level="2"><nlm:affiliation>AbbVie Inc, North Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>AbbVie Inc, North Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Geng, Ziqian" sort="Geng, Ziqian" uniqKey="Geng Z" first="Ziqian" last="Geng">Ziqian Geng</name>
<affiliation wicri:level="2"><nlm:affiliation>AbbVie Inc, North Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>AbbVie Inc, North Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Williams, David A" sort="Williams, David A" uniqKey="Williams D" first="David A" last="Williams">David A. Williams</name>
<affiliation wicri:level="2"><nlm:affiliation>AbbVie Inc, North Chicago, Illinois.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>AbbVie Inc, North Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Rich, Phoebe A" sort="Rich, Phoebe A" uniqKey="Rich P" first="Phoebe A" last="Rich">Phoebe A. Rich</name>
<affiliation wicri:level="2"><nlm:affiliation>Oregon Health and Science University Hospital, Portland, Oregon.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Oregon</region>
</placeName>
<wicri:cityArea>Oregon Health and Science University Hospital, Portland</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<idno type="eISSN">1097-6787</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Previous clinical trials have not evaluated improvement in nail psoriasis as a primary end point.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Alabama</li>
<li>Californie</li>
<li>Illinois</li>
<li>Nouvelle-Aquitaine</li>
<li>Oregon</li>
<li>Pennsylvanie</li>
<li>Poitou-Charentes</li>
<li>Wisconsin</li>
</region>
<settlement><li>Poitiers</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Alabama"><name sortKey="Elewski, Boni E" sort="Elewski, Boni E" uniqKey="Elewski B" first="Boni E" last="Elewski">Boni E. Elewski</name>
</region>
<name sortKey="Crowley, Jeffrey J" sort="Crowley, Jeffrey J" uniqKey="Crowley J" first="Jeffrey J" last="Crowley">Jeffrey J. Crowley</name>
<name sortKey="Geng, Ziqian" sort="Geng, Ziqian" uniqKey="Geng Z" first="Ziqian" last="Geng">Ziqian Geng</name>
<name sortKey="Gu, Yihua" sort="Gu, Yihua" uniqKey="Gu Y" first="Yihua" last="Gu">Yihua Gu</name>
<name sortKey="Okun, Martin M" sort="Okun, Martin M" uniqKey="Okun M" first="Martin M" last="Okun">Martin M. Okun</name>
<name sortKey="Rich, Phoebe A" sort="Rich, Phoebe A" uniqKey="Rich P" first="Phoebe A" last="Rich">Phoebe A. Rich</name>
<name sortKey="Sundaram, Murali" sort="Sundaram, Murali" uniqKey="Sundaram M" first="Murali" last="Sundaram">Murali Sundaram</name>
<name sortKey="Williams, David A" sort="Williams, David A" uniqKey="Williams D" first="David A" last="Williams">David A. Williams</name>
</country>
<country name="Canada"><noRegion><name sortKey="Papp, Kim" sort="Papp, Kim" uniqKey="Papp K" first="Kim" last="Papp">Kim Papp</name>
</noRegion>
<name sortKey="Poulin, Yves" sort="Poulin, Yves" uniqKey="Poulin Y" first="Yves" last="Poulin">Yves Poulin</name>
</country>
<country name="Australie"><noRegion><name sortKey="Baker, Christopher S" sort="Baker, Christopher S" uniqKey="Baker C" first="Christopher S" last="Baker">Christopher S. Baker</name>
</noRegion>
</country>
<country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Guillet, Gerard" sort="Guillet, Gerard" uniqKey="Guillet G" first="Gérard" last="Guillet">Gérard Guillet</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001230 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001230 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28993005
   |texte=   Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28993005" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.